Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (69)
  • 2024 (90)
  • 2023 (75)
  • 2022 (71)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Diversion Division (250)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Fentanyl Awareness (158)

Drug Name

  • Fentanyl (108)
  • Opioids (50)
  • Oxycodone (48)
  • Methamphetamine (17)
  • Synthetic Opioids (17)
  • Hydromorphone (14)
  • Cocaine (10)
  • Morphine (8)
  • Benzodiazepines (7)
  • Heroin (7)
  • Ketamine (3)
  • Marijuana (Cannabis) (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Washington, DC (43)
  • St. Louis (39)
  • Houston (35)
  • New York (27)
  • Miami (22)
  • Omaha (22)
  • Chicago (20)
  • Louisville (19)
  • Atlanta (18)
  • Sede (18)
  • Rocky Mountain (15)
  • El Paso (14)
  • Los Angeles (14)
  • New Jersey (14)
  • Seattle (14)
  • New Orleans (11)
  • San Francisco (9)
  • Dallas (8)
  • New England (7)
  • Phoenix (7)
  • San Diego (6)
  • Philadelphia (1)
Clear All Results
384 Results - Showing 291 to 300
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
PRESS RELEASE

Richland Naturopath Agrees to Pay $70,096 for Improper Prescription of Controlled Substances

Richland, Wash. – Judith K. Caporiccio, N.D., a Richland-based naturopathic doctor, has agreed to pay $70,096 to resolve allegations under the Controlled Substances Act and the False Claims Act, which allege that she improperly prescribed controlled substances between July 2016 and July 2021. The Controlled Substances Act regulates certain drugs...
PRESS RELEASE

Pharmacist Indicted for Tampering with a Controlled Substance

KANSAS CITY, Kan. – A federal grand jury in Kansas City returned an indictment charging a pharmacist with one count of tampering with a consumer product, one count of possession of tramadol by deception and subterfuge, one count of possession of zolpidem by deception and subterfuge, and one count of...
PRESS RELEASE

Illinois Dentist Charged with Tampering with Drugs Administered to Patients and Other Crimes

SPRINGFIELD, Ill. – Robert Bell, Special Agent in Charge of the Drug Enforcement Administration-Chicago Division, and U.S. Attorney Gregory K. Harris of the Central District of Illinois announced that a federal grand jury returned an indictment against Phillip Jensen, DMD, 61, of Rochester, Illinois, on Feb. 1, 2022, charging him...
PRESS RELEASE

Mesa Nurse Practitioner Indicted Over Alleged Illegal Opioid Prescribing Practices

PHOENIX - Nurse Practitioner Deborah Ann Cooney, 59 years old, has been indicted on 14 criminal charges related to her alleged illegal opioid prescribing practices at a clinic she operates in Mesa, Arizona. The investigation conducted by the Phoenix Office of the Drug Enforcement Administration (DEA) developed allegations of improper...
PRESS RELEASE

DEA Houston Shuts Down Wholesale Rx Inc. Distribution Operations

HOUSTON, TX – Today, Drug Enforcement Administration Houston Division diversion investigators served an Immediate Suspension Order (ISO) that immediately suspended the DEA registration held by Wholesale Rx also known as “Tyler Pharmaceuticals” located in Cordova, TN. Wholesale Rx is suspected of diverting controlled substances onto the black market resulting in...
PRESS RELEASE

New Jersey Doctor Charged with 34 Counts of Unlawful Distribution of Controlled Substances

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Passaic County, New Jersey, doctor was charged today with multiple counts of illegally prescribing medicines to his patients...
PRESS RELEASE

North Carolina Pharmacy Agrees to Pay $100,000 Fine

DURHAM, N.C. – Aspirar Pharmacy, LLC and Aspirar Pharmacy of Durham, LLC (collectively Aspirar Pharmacy), located in Cary and Durham, North Carolina, respectively, have agreed to pay the United States $100,000 to resolve allegations that they violated the Controlled Substances Act from 2017-2018 by filling prescriptions for a physician who...
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...
PRESS RELEASE

Florida-Based Pharmaceutical President Indicted in Counterfeit Promethazine-Codeine Drug Trafficking Conspiracy

BEAUMONT, Texas – A federal grand jury in Beaumont has returned a three-count indictment charging a Florida resident, along with nine other individuals, in a drug trafficking conspiracy in the Eastern District of Texas, announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S...

Paginación

  • Primera página «
  • Anterior
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Current page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster